Citadel Advisors’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.7M | Buy |
|
|||||
|
2025
Q2 | $8.43M | Sell |
|
|||||
|
2025
Q1 | $7M | Buy |
|
|||||
|
2024
Q4 | $2.63M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $219K | Buy |
|
|||||
|
2024
Q1 | $152K | Sell |
|
|||||
|
2023
Q4 | $234K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $883 | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $7.73K | Sell |
|
|||||
|
2022
Q3 | $95K | Sell |
|
|||||
|
2022
Q2 | $162K | Buy |
|
|||||
|
2022
Q1 | $326K | Sell |
|
|||||
|
2021
Q4 | $1.28M | Buy |
|
|||||
|
2021
Q3 | $402K | Sell |
|
|||||
|
2021
Q2 | $776K | Sell |
|
|||||
|
2021
Q1 | $1.26M | Sell |
|
|||||
|
2020
Q4 | $2.75M | Buy |
|
|||||
|
2020
Q3 | $1.05M | Buy |
|
|||||
|
2020
Q2 | $662K | Sell |
|
|||||
|
2020
Q1 | $1.66M | Sell |
|
|||||
|
2019
Q4 | $5.74M | Buy |
|
|||||
|
2019
Q3 | $1.45M | Buy |
|
|||||
|
2019
Q2 | $497K | Buy |
|
|||||
|
2019
Q1 | $265K | Sell |
|
|||||
|
2018
Q4 | $7.96M | Buy |
|
|||||
|
2018
Q3 | $8.76M | Buy |
|
|||||
|
2018
Q2 | $6.19M | Buy |
|
|||||
|
2018
Q1 | $2.19M | Buy |
|
|||||
|
2017
Q4 | – | Hold |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $294K | Sell |
|
|||||
|
2017
Q1 | $603K | Buy |
|
|||||
|
2016
Q4 | $409K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $193K | Buy |
|
|||||
|
2016
Q1 | $190K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $616K | Buy |
|
|||||
|
2015
Q2 | $87K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $361K | Buy |
|